Elevance Health, Inc. operates a health benefits and healthcare services platform built around affiliated health plans and the Carelon services business. Recurring company news covers Health Benefits results, premium yields, medical-cost trends, Medicaid, Medicare Advantage and employer group membership, and Carelon activity in pharmacy services, behavioral health, value-based care, care delivery, clinical, home health and complex care solutions.
Company updates also address small and midsize employer benefit offerings such as Balanced Funding and MEWAs, primary-care recognition and value-based provider programs, partnerships tied to family and community health, annual and quarterly financial guidance, and leadership changes across Health Benefits and Carelon.
Elevance Health has announced that its affiliated Medicare Advantage plans received an overall 4 out of 5 Star rating from the Centers for Medicare & Medicaid Services (CMS) for 2023. Notably, 64% of beneficiaries will enroll in plans rated 4 Stars or higher. Some plans, including HealthSun Health Plans and Optimum Healthcare, achieved the maximum 5 Star rating for multiple years. This success is attributed to improved consumer experiences and a focus on digital innovations aimed at enhancing health outcomes.
Elevance Health (NYSE: ELV) will announce its third-quarter 2022 financial results on October 19, 2022, at 6:00 a.m. EDT. A conference call will follow at 8:30 a.m. EDT, accessible by dialing the provided numbers. The access code for the call is 3972058. A replay will be available from 11:30 a.m. EDT on the same day until November 18, 2022. Elevance Health serves over 118 million consumers with a diverse range of health solutions, aiming to enhance human health.
Elevance Health announces substantial financial support for recovery efforts in the wake of Hurricane Ian. The company is donating a total of $2.7 million to various disaster relief organizations to assist Florida and other affected communities. Key contributions include $1 million each to the Florida Disaster Relief fund and the American Red Cross, along with additional funding to Americares, Direct Relief, and Rebuilding Together. These initiatives aim to provide critical medical supplies and support to over 1 million members of affiliated health plans.
Zylorion Health Inc. has announced the appointments of Jeroen Tas to its Board of Directors and Ted Goldstein to its Digital Health Advisory Committee. Tas, former Chief Innovation and Strategy Officer at Philips, and Goldstein, ex-Chief Artificial Intelligence Officer at Elevance Health, bring extensive experience in health technologies and bioinformatics. CEO Peter Silverstone expressed enthusiasm over their addition, highlighting their potential contributions to Zylorion's mission of delivering innovative therapies for mental health challenges, including MDD, TRD, and PTSD.
Elevance Health (NYSE: ELV) announced a partnership with Aledade to enhance consumer experiences and health outcomes in independent primary care. This collaboration aims to assist these providers in transitioning to value-based care, improving patient outcomes and reducing costs. With access to Aledade’s technology and support services, independent practices can strengthen their operations while serving 47 million members in Elevance's networks. The initiative is positioned to empower physicians and enrich primary care across communities.
New research by the Urban Institute, American Benefits Council, and Deloitte's Health Equity Institute, funded by Elevance Health, highlights the importance of high-quality race and ethnicity data in addressing health disparities. The report identifies challenges related to inconsistent data, which hinders the tracking of health inequities. Key recommendations include enhancing community engagement, ensuring data privacy, and modernizing data collection practices to promote health equity. The COVID-19 pandemic has intensified the urgency for comprehensive data to tailor care for marginalized communities.
Elevance Health, Inc. (NYSE: ELV) reported impressive second-quarter 2022 results with a GAAP net income of $6.79 per share, adjusted to $8.04, reflecting a 14.4% year-over-year increase. Operating revenue rose 15.6% to $38.5 billion, bolstered by a 2.7 million increase in medical enrollment, totaling 47.1 million members. The company declared a third-quarter dividend of $1.28 per share. With strong performance across segments, Elevance raised its 2022 earnings outlook to expect GAAP net income exceeding $25.28 per share.
Elevance Health (NYSE: ELV) will announce its second quarter 2022 financial results on July 20, 2022, at 6:00 a.m. EDT. A conference call to discuss these results and the company's outlook will follow at 8:30 a.m. EDT. Investors can join the call via various numbers or through a live webcast on www.elevancehealth.com. The call replay will be available from 11:30 a.m. EDT on July 20 until August 20, 2022.
Elevance Health serves over 118 million individuals with comprehensive care solutions.
Elevance Health has officially rebranded, marked by the ringing of the opening bell at the New York Stock Exchange. President and CEO Gail K. Boudreaux led the ceremony, accompanied by board members and senior leaders. As part of the rebranding, the company will now trade under the ticker symbol ELV. Elevance Health serves over 118 million individuals through a variety of health solutions, aiming to improve overall health outcomes.